Linganisha mbinu

	Vigezo vya Utambuzi vya Rome IV kwa Ugonjwa wa Utumbo unaowashwawashwa	Fahirisi ya Dalili Muhimu za Gastroparesis
Nyanja	Gastroenterolojia	Gastroenterolojia
Familia	Process / pipeline	Process / pipeline
Mwaka wa asili	2016	2003
Mwanzilishi	Rome Foundation (multinational expert consensus)	Revicki, D. A., Rentz, A. M., Dubois, D., et al.
Aina	Diagnostic Criteria	Self-report
Chanzo asilia	Mearin, F., Lacy, B. E., Chang, L., et al. (2016). Bowel disorders. Gastroenterology. Published online June 2016 by the Rome Foundation.	Revicki, D. A., Rentz, A. M., Dubois, D., Kahrilas, P., Stanghellini, V., Talley, N. J., & Tack, J. (2003). Development and validation of a patient-assessed gastroparesis symptom severity index. Alimentary Pharmacology & Therapeutics, 18(1), 141–150.
Majina mbadala	Rome IV IBS, Rome Criteria	GCSI
Zinazohusiana	4	4
Muhtasari	The Rome IV criteria are the internationally accepted diagnostic standard for irritable bowel syndrome (IBS), published in 2016 by the Rome Foundation. These criteria define IBS as recurrent abdominal pain (≥1 day per week for ≥3 months) associated with altered bowel habits, without structural or biochemical abnormalities. IBS is subtyped into four patterns—IBS-constipation predominant (IBS-C), IBS-diarrhea predominant (IBS-D), IBS-mixed (IBS-M), and IBS-unclassified (IBS-U)—based on stool consistency patterns.	The Gastroparesis Cardinal Symptom Index (GCSI) is a validated, patient-reported outcome measure specifically designed to assess symptom severity in gastroparesis. Developed by Revicki and colleagues in 2003, the GCSI captures the three cardinal symptom clusters of gastroparesis: nausea and vomiting, postprandial fullness, and early satiety, plus bloating and stomach distension. The 9-item questionnaire is responsive to treatment changes and is increasingly used in clinical trials and practice to monitor gastroparesis progression and therapy response.